As of April 25, 2021 the CDC and the U.S. Food and Drug Administration (FDA) recommend use of Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 Vaccine resume in the United States, after a temporary pause. The information below is an...
Read More ›The CDC and FDA have recommended a pause in the use of the Johnson & Johnson COVID-19 vaccine out of an abundance of caution after six reported U.S. cases (out of more than 6.8 million doses) of a rare and severe type of blood clot in...
Read More ›FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine On February 27, 2021, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019...
Read More ›